219 related articles for article (PubMed ID: 32125290)
1. Ubiquitous antigen-specific T regulatory type 1 cells variably suppress hepatic and extrahepatic autoimmunity.
Umeshappa CS; Mbongue J; Singha S; Mohapatra S; Yamanouchi J; Lee JA; Nanjundappa RH; Shao K; Christen U; Yang Y; Ellestad KK; Santamaria P
J Clin Invest; 2020 Apr; 130(4):1823-1829. PubMed ID: 32125290
[TBL] [Abstract][Full Text] [Related]
2. Quantifying immunoregulation by autoantigen-specific T-regulatory type 1 cells in mice with simultaneous hepatic and extra-hepatic autoimmune disorders.
Jamaleddine H; Santamaria P; Khadra A
Immunology; 2020 Nov; 161(3):209-229. PubMed ID: 32687611
[TBL] [Abstract][Full Text] [Related]
3. Suppression of a broad spectrum of liver autoimmune pathologies by single peptide-MHC-based nanomedicines.
Umeshappa CS; Singha S; Blanco J; Shao K; Nanjundappa RH; Yamanouchi J; Parés A; Serra P; Yang Y; Santamaria P
Nat Commun; 2019 May; 10(1):2150. PubMed ID: 31089130
[TBL] [Abstract][Full Text] [Related]
4. Expanding antigen-specific regulatory networks to treat autoimmunity.
Clemente-Casares X; Blanco J; Ambalavanan P; Yamanouchi J; Singha S; Fandos C; Tsai S; Wang J; Garabatos N; Izquierdo C; Agrawal S; Keough MB; Yong VW; James E; Moore A; Yang Y; Stratmann T; Serra P; Santamaria P
Nature; 2016 Feb; 530(7591):434-40. PubMed ID: 26886799
[TBL] [Abstract][Full Text] [Related]
5. Re-Programming Autoreactive T Cells Into T-Regulatory Type 1 Cells for the Treatment of Autoimmunity.
Solé P; Santamaria P
Front Immunol; 2021; 12():684240. PubMed ID: 34335585
[TBL] [Abstract][Full Text] [Related]
6. Liver-specific T regulatory type-1 cells program local neutrophils to suppress hepatic autoimmunity via CRAMP.
Umeshappa CS; Solé P; Surewaard BGJ; Yamanouchi J; Mohapatra S; Uddin MM; Clarke R; Ortega M; Singha S; Mondal D; Yang Y; Vignali DAA; Serra P; Kubes P; Santamaria P
Cell Rep; 2021 Mar; 34(13):108919. PubMed ID: 33789099
[TBL] [Abstract][Full Text] [Related]
7. Retinoic acid-induced autoantigen-specific type 1 regulatory T cells suppress autoimmunity.
Raverdeau M; Christofi M; Malara A; Wilk MM; Misiak A; Kuffova L; Yu T; McGinley AM; Quinn SM; Massilamany C; Reddy J; Forrester JV; Mills KH
EMBO Rep; 2019 May; 20(5):. PubMed ID: 30894405
[TBL] [Abstract][Full Text] [Related]
8. Nanoparticle-based autoantigen delivery to Treg-inducing liver sinusoidal endothelial cells enables control of autoimmunity in mice.
Carambia A; Freund B; Schwinge D; Bruns OT; Salmen SC; Ittrich H; Reimer R; Heine M; Huber S; Waurisch C; Eychmüller A; Wraith DC; Korn T; Nielsen P; Weller H; Schramm C; Lüth S; Lohse AW; Heeren J; Herkel J
J Hepatol; 2015 Jun; 62(6):1349-56. PubMed ID: 25617499
[TBL] [Abstract][Full Text] [Related]
9. Effects and regulation of autoreactive CD8+ T cells in a transgenic mouse model of autoimmune hepatitis.
Zierden M; Kühnen E; Odenthal M; Dienes HP
Gastroenterology; 2010 Sep; 139(3):975-86, 986.e1-3. PubMed ID: 20639127
[TBL] [Abstract][Full Text] [Related]
10. Analysis of autoreactive CD4 T cells in experimental autoimmune encephalomyelitis after primary and secondary challenge using MHC class II tetramers.
Bischof F; Hofmann M; Schumacher TN; Vyth-Dreese FA; Weissert R; Schild H; Kruisbeek AM; Melms A
J Immunol; 2004 Mar; 172(5):2878-84. PubMed ID: 14978089
[TBL] [Abstract][Full Text] [Related]
11. Induction of autoantigen-specific Th2 and Tr1 regulatory T cells and modulation of autoimmune diabetes.
Chen C; Lee WH; Yun P; Snow P; Liu CP
J Immunol; 2003 Jul; 171(2):733-44. PubMed ID: 12847240
[TBL] [Abstract][Full Text] [Related]
12. MHC-mismatched mixed chimerism augments thymic regulatory T-cell production and prevents relapse of EAE in mice.
Wu L; Li N; Zhang M; Xue SL; Cassady K; Lin Q; Riggs AD; Zeng D
Proc Natl Acad Sci U S A; 2015 Dec; 112(52):15994-9. PubMed ID: 26647186
[TBL] [Abstract][Full Text] [Related]
13. Ectopic expression of neural autoantigen in mouse liver suppresses experimental autoimmune neuroinflammation by inducing antigen-specific Tregs.
Lüth S; Huber S; Schramm C; Buch T; Zander S; Stadelmann C; Brück W; Wraith DC; Herkel J; Lohse AW
J Clin Invest; 2008 Oct; 118(10):3403-10. PubMed ID: 18802476
[TBL] [Abstract][Full Text] [Related]
14. A Tolerogenic Artificial APC Durably Ameliorates Experimental Autoimmune Encephalomyelitis by Directly and Selectively Modulating Myelin Peptide-Autoreactive CD4
Wan X; Pei W; Shahzad KA; Zhang L; Song S; Jin X; Wang L; Zhao C; Shen C
J Immunol; 2018 Aug; 201(4):1194-1210. PubMed ID: 29987163
[TBL] [Abstract][Full Text] [Related]
15. Adaptive immunity in autoimmune hepatitis.
Longhi MS; Ma Y; Mieli-Vergani G; Vergani D
Dig Dis; 2010; 28(1):63-9. PubMed ID: 20460892
[TBL] [Abstract][Full Text] [Related]
16. Peptide-MHC-Based Nanomedicines for the Treatment of Autoimmunity: Engineering, Mechanisms, and Diseases.
Serra P; Santamaria P
Front Immunol; 2020; 11():621774. PubMed ID: 33574822
[TBL] [Abstract][Full Text] [Related]
17. Differential modulation of CNS-specific effector and regulatory T cells during tolerance induction by recombinant invariant chains in vivo.
Lange C; Doster H; Steinbach K; Kalbacher H; Scholl M; Melms A; Bischof F
Brain Behav Immun; 2009 Aug; 23(6):861-7. PubMed ID: 19362139
[TBL] [Abstract][Full Text] [Related]
18. Specific T regulatory cells display broad suppressive functions against experimental allergic encephalomyelitis upon activation with cognate antigen.
Yu P; Gregg RK; Bell JJ; Ellis JS; Divekar R; Lee HH; Jain R; Waldner H; Hardaway JC; Collins M; Kuchroo VK; Zaghouani H
J Immunol; 2005 Jun; 174(11):6772-80. PubMed ID: 15905518
[TBL] [Abstract][Full Text] [Related]
19. Tolerogenic Nanoparticles Induce Antigen-Specific Regulatory T Cells and Provide Therapeutic Efficacy and Transferrable Tolerance against Experimental Autoimmune Encephalomyelitis.
LaMothe RA; Kolte PN; Vo T; Ferrari JD; Gelsinger TC; Wong J; Chan VT; Ahmed S; Srinivasan A; Deitemeyer P; Maldonado RA; Kishimoto TK
Front Immunol; 2018; 9():281. PubMed ID: 29552007
[TBL] [Abstract][Full Text] [Related]
20. Failure of thymic deletion and instability of autoreactive Tregs drive autoimmunity in immune-privileged liver.
Preti M; Schlott L; Lübbering D; Krzikalla D; Müller AL; Schuran FA; Poch T; Schakat M; Weidemann S; Lohse AW; Weiler-Normann C; Sebode M; Schwinge D; Schramm C; Carambia A; Herkel J
JCI Insight; 2021 Mar; 6(6):. PubMed ID: 33600378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
